Abstract
Pulmonary granulomas—the hallmark of Mycobacterium tuberculosis (MTB) infection—are dense cellular lesions that often feature regions of hypoxia and necrosis, partially due to limited transport of oxygen. Low oxygen in granulomas can impair the host immune response, while MTB are able to adapt and persist in hypoxic environments. Here, we used a physiologically based mathematical model of oxygen diffusion and consumption to calculate oxygen profiles within the granuloma, assuming Michaelis–Menten kinetics. An approximate analytical solution—using a priori and newly estimated parameters from experimental data in a rabbit model of tuberculosis—was able to predict the size of hypoxic and necrotic regions in agreement with experimental results from the animal model. Such quantitative understanding of transport limitations can inform future tuberculosis therapeutic strategies that may include adjunct host-directed therapies that facilitate oxygen and drug delivery for more effective treatment.
Keywords: Diffusion, Mycobacterium tuberculosis, Michaelis, Menten kinetics, Rabbit model, Pimonidazole
INTRODUCTION
As one of the most virulent infectious diseases in the world today, tuberculosis (TB) accounts for almost 2 million deaths and 2 billion latent infections annually.15 While current treatment regimens are largely successful in curing the infection, multi-drug resistant Mycobacterium tuberculosis (MTB) strains have proliferated, in part due to poor adherence to the 6-month duration of standard treatment.42,56 Clearly, a better understanding of the physiochemical characteristics of tuberculosis pathology and progression would help in the development of more effective treatment protocols. TB progression—and, inevitably, treatment response—is governed by the formation and evolution of pulmonary granulomas, the primary sites of infection.
TB granulomas are dense cellular masses, comprised primarily of immune cells, that form in the lungs in response to MTB infection.16,36 Some granulomas recruit new blood vessels in the peripheral regions of the tissue mass that abut the healthy lung tissue.34,41 These angiogenic vessels presumably allow granulomas to grow to sizes that exceed the diffusion distance of oxygen (<200 μm from a vessel8,46). Tuberculosis granulomas typically contain hypoxic regions48 resulting in altered MTB metabolism.38,39 These hypoxic areas often surround necrotic cores (Fig. 1), which are regions comprised of lipid-rich, cellular debris.13,37
MTB has been shown to be responsive to changes in oxygen tension; indeed, many in vivo and in vitro models have demonstrated that bacterial growth, metabolic activity, and transcriptional profiles are altered by hypoxia.25,28,38,40 Some mycobacteria are able to shift to a dormant phenotype of “bacteriostasis,” or non- or slow-replication, that can persist for years.5,39,49–51 Furthermore, some bacilli undergo transcriptional adaptations that reduce drug susceptibility in hypoxic conditions.27,50 This suggests a prominent role of oxygen in the latency and reactivation of the TB bacilli. Additionally, we have recently shown that granulomas are associated with abnormal vasculature, thus compromising the effective delivery of oxygen and TB drugs.11
Interestingly, a very different disease that evolves in a similar manner is cancer, in that it also produces dense tissue masses, i.e., tumors, with abnormal vasculature and resulting regions of hypoxia and necrosis. The physiological abnormalities that characterize solid cancerous tumors have, in fact, been investigated thoroughly23; it is now well known that these unique properties—most notably, irregular, spatially and temporally heterogeneous vascular networks—compromise the delivery of oxygen, nutrients, drugs and immune cells within the tumor tissue.8,20–22 Furthermore, hypoxia is known to drive immunosuppression in tumors 24; this may occur in the hypoxic granuloma regions, although this has yet to be confirmed.
The physiological similarities between solid tumors and TB granulomas motivate a quantitative understanding of the underlying transport limitations within granulomas. To this end, the present work describes the limits of oxygen transport within TB granulomas via a mathmatical modeling approach originally applied to tumors. Oncology has long benefitted from the use of these models to illuminate biological processes associated with tumor progression. While these models can become rather complex, especially when describing dynamic processes such as angiogenesis,31,44 simpler mathematical models of avascular tumors can reveal highly relevant insight about early, macro-scale mechanisms of tumor growth.2,35 In particular, heterogeneous avascular models are used to describe stratified layers of a tumor mass—such as non-necrotic vs. necrotic regions—based on oxygen distribution.26,35 Deakin12 was the first to develop an analytical model for the emergence of necrotic cores in tumor spheroids based on the assumption that the oxygen consumption in avascular tumors is constant, or zero-order, with respect to oxygen concentration, until the concentration decreases due to cellular consumption to a low value, below which the consumption is first-order, i.e., proportional to the concentration.12 As the oxygen concentration decreases further, a critical concentration is reached at which cells die and necrosis occurs. These assumptions of oxygen concentration match the so-called Michaelis–Menten (MM) mitochondrial oxygen consumption kinetics,7,10,29,52,53 employed in later biological43 and avascular tumor models.19,26
Here we developed a theoretical model of oxygen diffusion and consumption, based on the rich avascular tumor model literature, for TB granulomas. Previously reported and newly collected experimental data provide relevant parameters for the model. Model predictions of hypoxia and necrosis are in concert with experimental results from a rabbit model of TB. Moreover, this model serves to provide a conceptual framework within which the experimental observations can be quantitatively interpreted, and represents the first step toward understanding and eventually overcoming the transport limitations within TB granulomas.
MATERIALS AND METHODS
The parameter values used in this model can be found in Table 1. The basic formulation steps and assumptions of the model are given below. To make our work accessible to a broad readership, the detailed derivation and justification of parameter values are provided in the Supporting Material.
TABLE 1.
Parameter | Value | Units | References | |
---|---|---|---|---|
|
1.34 × 10−9 | mol O2/cm3–mmHg | 47 | |
|
2.5 × 10−5 | cm2/s | Adapted from 9, 18, 47 | |
|
60 | mmHg | 48 | |
|
10 | mmHg | 3, 14, 32 | |
|
2 | mmHg | 48 | |
|
8.04 × 10−8 | mol O2/cm3 | From Henry’s law |
|
|
1.34 × 10−8 | mol O2/cm3 | From Henry’s law |
|
|
2.68 × 10−9 | mol O2/cm3 | From Henry’s law |
|
k | 1.09 | s−1 | From Eqs. (18) and (19) | |
K | 7.46 × 107 | cm3/mol O2 | From Eq. (20) |
Model Formulation and Assumptions
Figure 1 shows the stratification of cellular/vascular layers based on oxygen availability in a representative TB granuloma. From this morphology, four distinct areas can be described: (1) a necrotic core surrounded by (2) a region where cells are hypoxic, (3) a region where cells are not hypoxic although blood vessels do not exist, and (4) an outer non-hypoxic region where blood vessels exist (“vascularized region”). The tissue area between the regions where vessels exist and the necrotic core, i.e., the region between the yellow and white demarcations in Fig. 1, represents the “avascular region,” where oxygen is delivered by diffusion only.
In the idealized schematic in Fig. 2, the granuloma is considered as a spherical particle. Figure 2a denotes four radii of interest (measured experimentally via image analysis methods described in the Supporting Material): (1) the outer granuloma radius, R0, (2) the radius of the avascular region, R, (3) the radius of the hypoxic region, RH (indicated experimentally by positive pimonidazole stain, as described in the Supporting Material), and (4) the radius of the necrotic core, RC (indicated experimentally by the presence of cellular debris and lack of viable cells). The regions and radii depicted in Fig. 2a have corresponding oxygen concentrations, , and oxygen consumption rates, , shown schematically in Fig. 2b. It is assumed that the perfused (i.e., vascularized) region (R0 to R) has a uniform bulk concentration of oxygen ( ), resulting from an adequate supply of oxygen from the local vasculature. Starting at the boundary of the avascular region (r = R) and moving towards the granuloma center, the oxygen concentration decreases (from ) with distance into the granuloma interior due to cellular consumption until it reaches a concentration at which cells become hypoxic ( ), as indicated by positive pimonidazole staining (Fig. 1), at granuloma radius r = RH. Within the hypoxic region (r < RH), the oxygen concentration decreases further from until it reaches a critical oxygen concentration ( )12,26 at which cells die, i.e., necrosis sets in, at a granuloma radius, r < RC. Throughout the necrotic core (r < RC) the oxygen concentration remains at a constant value of , because there is no longer any cellular consumption of oxygen (i.e., ). The respective oxygen concentrations are defined numerically as model parameters in the Supporting Material.
As described in the Supporting Material, the experimental data used to determine parameter values and to make comparisons to the mathematical model predictions come from granulomas at a state of disease progression where the granuloma size is essentially static, i.e., the macroscopic growth rate of these lesions can be considered zero. Therefore, oxygen transport in an idealized avascular granuloma can be written as a one-dimensional mass balance equation (see Eqs. (1) and (2) in the Supporting Material for details) as
where the first term on the left hand side describes the transport of oxygen in the granuloma tissue via diffusion and the second term on the left hand side is the Michaelis–Menten (MM) kinetic relation for oxygen consumption. The zero on the right hand side follows from the steady-state assumption, i.e., there is no accumulation of oxygen in the granuloma. Here, it is apparent that each term in the oxygen mass balance above is dependent on specific parameters; (1) the diffusion of oxygen is dependent on the effective diffusivity of oxygen in the granuloma interstitium ( ), and (2) the MM kinetic relation is dependent on two kinetic parameters (k and K).
In addition to the assumptions of specific oxygen concentrations at corresponding radii, we also assume that the flux of oxygen across these defined boundaries is continuous. Regarding the oxygen consumption term, the MM equation is considered to be adequate for describing the observed hyperbolic dependence of consumption rate on oxygen concentration.6,55 It does not, however, represent the true complexity of the mitochondrial processes regulating oxygen consumption. For instance, it does not reflect the fact that below a critical oxygen concentration the metabolic machinery shuts down resulting in cellular necrosis18; therefore, we include a boundary condition that satisfies this physical reality. Furthermore, MM kinetics can be reduced to limiting forms,47 based on the dependence of oxygen consumption on oxygen concentration. It is assumed here that the differential availability of oxygen in the hypoxic and non-hypoxic regions of the avascular region results in zero-order and first-order oxygen consumption kinetics in sub-regions I and II, respectively (Fig. 2b). Finally, we assume that the MTB within the granuloma core respire anaerobically, based on known adaptations to low oxygen conditions.
Thus, the physics of oxygen diffusion and consumption as described above are formulated mathematically for the TB granulomas as a system of ordinary differential equations in the Supporting Material, using a one-dimensional model with these boundary conditions.
Model Parameters
With the appropriate parameters, the radii of the necrotic and hypoxic regions, RC and RH, can be determined from the above mathematical model, and compared to experimental data from the rabbit model of TB. Clearly, the model predictions depend upon the reliability of the model parameters. In this study, all parameters, except for two physical parameters—k, the first-order rate constant from the MM kinetic expression for oxygen consumption, and , the effective diffusivity of oxygen in the granuloma interstitium (see the Supporting Material for further descriptions)—are determined from either a priori48 or new measurements from the rabbit experimental model. The justification for the choice of model parameters is given in the Supporting Material and the parameter values are summarized in Table 1.
Animal Experiments and Image Analysis
Untreated control tissues from a previously published experiment in the rabbit TB model11 were used to assess the hypoxic and necrotic radii in rabbit granulomas via histological image analysis for comparison to the model predictions (for details see the Supporting Material).
RESULTS
Based on the theoretical model assumptions and formulation above and in the Supporting Material, a system of nonlinear ordinary differential equations was developed here to describe oxygen transport in an idealized spherical TB granuloma. For ease of presentation, dimensionless variables are used to describe granuloma size and various radii (e.g., hypoxic and necrotic radii), MM kinetics, and oxygen concentration profiles in Figs. 3, 4, 5, and 6.
Numerical Results for Full Michaelis–Menten Kinetics
In the model presented, both the full expression of MM kinetics and the limiting forms of this expression (based on local oxygen concentration) are used to describe oxygen consumption in a TB granuloma. The full MM expression can be solved only numerically for oxygen concentration profiles, as shown in Fig. 3, for various values of the Thiele Modulus (ϕ) which is a dimensionless representation of the granuloma size as scaled with the rates of oxygen consumption and diffusivity (see the Supporting Material). As expected, we find that the oxygen concentration (f) drops quickly with distance into the granuloma core as the granuloma size (ϕ) increases. Further, the necrotic core radius (y = yC) can be determined graphically from where the numerical MM results intersect a horizontal line set at the critical value at which cells die, i.e., the critical concentration of oxygen (f = fC); similarly, the hypoxic radius (y = yH) can be determined graphically from the hypoxic concentration of oxygen (f = fH).
Figure 3 shows that only larger granulomas (ϕ > 5 corresponding to R > 0.2 mm) are necrotic. Furthermore, it is apparent that the kinetics predict an asymptotic approach to anoxia, i.e., an oxygen concentration of 0 (f = 0), which does not take into account that cells die at a non-zero critical oxygen concentration (fC) at the edge of the necrotic core where consumption of oxygen ends. This condition, while satisfied in the limiting forms of the MM kinetics, i.e., zero- and first-order kinetics as shown graphically in Fig. 2b (presented next and discussed further in the Supporting Material), stems inherently from the inability of the MM kinetics to account for the fact that the cells die below a critical oxygen level. Therefore, the estimates of concentration profiles and necrotic core size are only approximate using this method.
Comparison of Analytical Solution with Experimental Data for Hypoxic and Necrotic Radii
The size of the hypoxic and necrotic regions of the granuloma can alternately be directly determined via the analytical solutions for the limiting forms of the MM kinetics derived in the Supporting Material. For specified values of hypoxic (fH) and critical oxygen concentrations (fC), the hypoxic (yH) and necrotic (yC) granuloma radii can be determined for given normalized granuloma size (i.e., the ratio ϕ/ϕm, where ϕm is the minimum granuloma size with necrosis, as determined experimentally in the Supporting Material), as shown in Fig. 4. Figure 4 also includes the predicted values for the thickness of the hypoxic region (yH − yC).
As shown in Fig. 4, no necrotic core exists in small granulomas (ϕ/ϕm < 1), although hypoxia can arise. Furthermore, this analysis indicates that the hypoxic and necrotic radii increase dramatically with increasing normalized granuloma size for smaller granulomas ((ϕ/ϕm) < 2, corresponding to R < 0.6 mm), but then more gradually for larger granulomas ((ϕ/ϕm) > 2), i.e., for granulomas that are at least twice the size of the minimum granuloma particle size where necrosis occurs.
Finally, we recall that the main objective of this model is to predict the emergence of hypoxia and necrosis, and to compare theoretical results to experimental data from the rabbit model of TB. The theoretical dimensionless hypoxic and necrotic radii from Fig. 4 can be, thus, converted to dimensional values (in mm) and compared to experimentally measured values of RC and RH via image analysis (see Supplementary Table 1 in the Supporting Material) and plotted vs. R, the avascular granuloma radius from Fig. 2a, as shown in Fig. 5. Note that the model accurately predicts the size of hypoxic and necrotic regions as a function of granuloma size in agreement with the experimental results, and that the hypoxic region thickness (RH − RC) approaches a constant value for large granulomas.
Furthermore, from the predictions of the necrotic and hypoxic radii, based on defined critical and hypoxic oxygen concentrations, the oxygen concentration profiles can be plotted piecewise for the avascular region of the granuloma as shown in Fig. 6 for various values of dimensionless granuloma size (ϕ). Note the close agreement between oxygen concentration profiles resulting from the limiting forms of the MM kinetics compared to concentration profiles calculated numerically from the full MM kinetic expression in Fig. 6; in the piecewise solution, the oxygen concentration in the necrotic core is non-zero and cellular consumption ceases at this level (due to cell death).
DISCUSSION
Through mathematical modeling of the underlying transport processes in TB granulomas, we provide a quantitative framework for further understanding of the disease. Our model offers a predictive tool for characterizing oxygen concentration profiles and the amount of hypoxia and necrosis. Although the general concepts used here have been applied to many systems, ranging from catalyst particles17 to tumor spheroids,35 to our knowledge, this is the first model of oxygen transport in TB granulomas.
Model Features and Limitations
While hypoxia and necrosis, and the potential bacterial adaptations to these harsh microenvironmental conditions, are known to exist in TB granulomas, the root cause of the emergence of these heterogeneous tissue regions has not been elucidated. We propose, based on our recent experimental observations,11 that in TB, as in solid cancerous tumors, these conditions are largely the result of an abnormal granuloma-associated vasculature that results in hypoxia, especially in avascular regions. While other factors have been identified as potential causes of necrosis, such as breakdown of extracellular matrix1 and immune/inflammatory processes33 including cell death,30 this work definitively identifies oxygen as a major player in its emergence. While further studies are required to illuminate all of the physiological abnormalities and molecular mechanisms that may contribute to hypoxia and necrosis, the results of this simple model, in agreement with experimental data, quantitatively support the hypothesis that low oxygen supply is a key contributor of necrosis in TB granulomas.
To describe oxygen consumption kinetics in avascular granuloma regions, the model relies on the established Michaelis–Menten (MM) relation. We postulate here, based on the presence of hypoxia as confirmed from tissue histology (described fully in the Supporting Material), that the switch from first-order to zero-order kinetics—the limiting forms of the MM kinetic expression—occurs at a definitive concentration of oxygen at which the cells are metabolically compromised and considered hypoxic. Therefore, this provides a physiological rationale for the switching of the kinetics from zero-order (in abundant oxygen supply) to first-order (in limited oxygen supply).
Our model utilizes physiologically relevant parameters that were either measured a priori or calculated from newly collected data from historical controls from an unpublished animal experiment (as described in the Supporting Material); the results of the model (i.e., the predicted hypoxic and necrotic radii) are compared to experimental measurements from an independent data set. Furthermore, a macroscopic or continuum view of a homogeneous granuloma is employed here. However, this simplifies the varying cellular heterogeneity, functions and metabolic needs of the cell types that comprise a granuloma. For example, this model utilizes kinetic parameters that are assumed to apply to all host cells involved; in reality, lymphocytes, macrophages, and the other cells that comprise granulomas likely have varying metabolic rates and oxygen demands. Further, this model assumes that any bacterial cells in the granuloma metabolize anaerobically; however, it is possible that some surviving bacteria very close to the edge of the necrotic radius or in the hypoxic region may be utilizing oxygen for metabolism. In principle, it should be possible to model stratified layers of a granuloma not only based on local oxygen concentration, but also based on the local major cell type(s) and its corresponding oxygen uptake rate. This could be compared to experimental oxygen concentration profiles within granulomas. Finally, the MM kinetics, although well-accepted, are still only an approximation of cellular consumption kinetics. The actual oxygen consumption kinetics are likely more complex and controlled by the metabolic state of the cell in response to the local supply of oxygen and nutrients in the abnormal granuloma microenvironment.
Conclusions from the Model
The theoretical predictions of the size of the hypoxic and necrotic fractions of granulomas of various sizes seem to compare favorably with experimental results obtained from a rabbit TB model, keeping in mind that all parameters, except for two, were either assigned directly or determined from a priori measurements. In fact, since the ratio of the first-order rate constant for oxygen consumption and oxygen diffusivity can be determined from the minimum size of the granuloma particle with the beginnings of a necrotic core within it based on the definition of the Thiele Modulus for dimensionless granuloma size, as discussed in the Supporting Material, only one of these parameters is independent.
It is also noteworthy that similar to tumor spheroids, the model predicts, in agreement with the TB experimental data, that for granulomas of increasing size, the hypoxic region thickness remains essentially constant, implying that in the avascular region, only the necrotic region is growing with size over time. It is apparent from Fig. 5 that for smaller granulomas (R < 0.3 mm), the theoretical predictions of the hypoxic region thickness do not match as closely with the measured values as with larger granuloma sizes; this is likely because the assumption of one-dimensional transport in a sphere employed for the theoretical model becomes less accurate for smaller granulomas, due to increased surface area to volume ratios, when compared to experimental measurements from non-spherical granulomas.
Future Directions
By continuing to apply mathematical modeling approaches to elucidate the transport and kinetics of small molecules (e.g., glucose, therapeutic drugs) within TB granulomas, additional crucial aspects of the problem can be illuminated. As an example, it would be possible to develop a model of transport and kinetics of small molecules based on an arbitrary-shape representation of the granuloma geometry,4 rather than assuming a spherical shape. As another example, exploring the mechanism and kinetics of glycolysis and any aerobic metabolism helping mycobacteria survival within the necrotic core would be of interest. Modeling of TB granulomas would also benefit from improved parameter estimation/measurements (e.g., the effective diffusivity of oxygen).
Of note, the model presented here considers only the avascular (diffusive) region of a granuloma. It would be of great interest to develop a full model of small molecule convection and diffusion throughout the entire granuloma mass, which could further illuminate not only oxygen transport limitations but those of drugs as well, and help in developing chemotherapeutic strategies for overcoming these barriers. For example, we recently discovered that TB granulomas feature an abnormal vasculature that hinders the delivery of oxygen and drugs; we found that “normalizing” this vasculature with an anti-angiogenic agent resulted in improved small molecule delivery and a reduction of hypoxia, without increasing the granuloma bacterial burden.11 We postulate that, when administered in conjunction with anti-TB agents, such adjunct therapies that improve drug and oxygen delivery may enhance drug efficacy and the intra-granuloma immune response, thus benefitting treatment outcome. The effect of adjunct therapies that induce “vascular normalization” could be incorporated into a mathematical model that includes vascular and interstitial convection in order to assess any benefits to vascular function, and thus, drug delivery. Mathematical modeling could also be employed to predict the dosage and timing of such combination treatment strategies, as we have done in cancer,45 in order to ensure that the bacteria are eradicated by anti-TB drugs before they can exploit the resulting enhanced oxygenation.
Furthermore, the ability to predict the onset of hypoxia and necrosis in patients, based on granuloma sizes assessed from non-invasive imaging, could lead to altered therapeutic regimens. It is obvious from the TB literature that oxygen—specifically, hypoxia—can have profound and differing effects on MTB vs. host cell survival and metabolism,38,39,49–51 and, presumably, disease progression and outcome. If a patient has granulomas that are predicted to be hypoxic via this type of theoretical modeling on the basis of observable lesion size (e.g., from computed tomography scans), they may, for example, be administered pyrazinamide, a drug that has been shown to have anti-MTB effects in hypoxic conditions.54 Further, this model can also be readily adapted to predict the penetration of certain drugs into the granuloma based on binding kinetics.
Thus, by continuing to investigate physiological abnormalities and resulting transport limitations in TB granulomas, it is possible to reveal potential avenues through which the availability of oxygen and nutrients to the immune cells can be improved, as well as the delivery of anti-TB drugs to the bacteria that survive within the necrotic core, in an effort to combat this contagion that afflicts a large segment of the world’s population.
Supplementary Material
Acknowledgments
We thank Drs. Jerry Meldon and Stephen Matson for their insightful comments, and Drs. Vasileios Askoxylakis, Dai Fukumura, Giorgio Seano, Triantafyllos Stylianopoulos, and Joshua Tam for their assistance in manuscript editing. We would like to acknowledge Kathleen England, Daniel Schimel, and Danielle Weiner (Tuberculosis Research Section, Laboratory of Clinical Infectious Disease, National Institutes of Health/National Institute of Allergy and Infectious Diseases) for their technical assistance in the previously performed animal studies. Thanks to Carolyn Smith (Edwin L. Steele Laboratories, Massachusetts General Hospital/Harvard Medical School) for her support in the immunohistochemistry studies. This study was supported in part by Grants from the Bill and Melinda Gates Foundation (to R.K.J.), through the Grand Challenges in Global Health Program to Douglas Young, Imperial College (to C.E.B.), and from the Intramural Research Program of the NIH, NIAID (to C.E.B).
Footnotes
Associate Editor Aleksander S. Popel oversaw the review of this article.
ELECTRONIC SUPPLEMENTARY MATERIAL
The online version of this article (doi:10.1007/s10439-015-1415-3) contains supplementary material, which is available to authorized users.
CONFLICT OF INTEREST
R.K.J. received consultant fees from Xtuit, Ophthotech, SPARC, and SynDevRx. R.K.J. owns equity in Enlight, Ophthotech, SynDevRx, and XTuit and serves on the Board of Directors of XTuit and the Boards of Trustees of Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund. No reagents or funding from these companies were used in these studies.
References
- 1.Al Shammari B, Shiomi T, Tezera L, Bielecka MK, Workman V, Sathyamoorthy T, Mauri F, Jayasinghe SN, Robertson BD, D’Armiento J, Friedland JS, Elkington PT. The extracellular matrix regulates granuloma necrosis in tuberculosis. J Infect Dis. 2015;12:463–473. doi: 10.1093/infdis/jiv076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Araujo RP, McElwain DL. A history of the study of solid tumour growth: the contribution of mathematical modelling. Bull Math Biol. 2004;66:1039–1091. doi: 10.1016/j.bulm.2003.11.002. [DOI] [PubMed] [Google Scholar]
- 3.Arteel GE, Thurman RG, Raleigh JA. Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. Eur J Biochem. 1998;253:743–750. doi: 10.1046/j.1432-1327.1998.2530743.x. [DOI] [PubMed] [Google Scholar]
- 4.Baish JW, Stylianopoulos T, Lanning RM, Kamoun WS, Fukumura D, Munn LL, Jain RK. Scaling rules for diffusive drug delivery in tumor and normal tissues. Proc Natl Acad Sci USA. 2011;108:1799–1803. doi: 10.1073/pnas.1018154108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Boon C, Dick T. Mycobacterium bovis BCG response regulator essential for hypoxic dormancy. J Bacteriol. 2002;184:6760–6767. doi: 10.1128/JB.184.24.6760-6767.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Boveris A, Costa LE, Poderoso JJ, Carreras MC, Cadenas E. Regulation of mitochondrial respiration by oxygen and nitric oxide. Ann N Y Acad Sci. 2000;899:121–135. doi: 10.1111/j.1749-6632.2000.tb06181.x. [DOI] [PubMed] [Google Scholar]
- 7.Casciari JJ, Sotirchos SV, Sutherland RM. Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH. J Cell Physiol. 1992;151:386–394. doi: 10.1002/jcp.1041510220. [DOI] [PubMed] [Google Scholar]
- 8.Chauhan VP, Stylianopoulos T, Boucher Y, Jain RK. Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. Annu Rev Chem Biomol Eng. 2011;2:281–298. doi: 10.1146/annurev-chembioeng-061010-114300. [DOI] [PubMed] [Google Scholar]
- 9.Chen J, Layton AT, Edwards A. A mathematical model of O2 transport in the rat outer medulla. I. Model formulation and baseline results. Am J Physiol Ren Physiol. 2009;297:F517–F536. doi: 10.1152/ajprenal.90496.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Cronk J, Schubert RW. Michaelis-Menten-like kinetics in the Krogh tissue cylinder. Adv Exp Med Biol. 1984;180:499–509. doi: 10.1007/978-1-4684-4895-5_47. [DOI] [PubMed] [Google Scholar]
- 11.Datta M, Via LE, Kamoun WS, Liu C, Chen W, Seano G, Weiner DM, Schimel D, England K, Martin JD, Gao X, Xu L, Barry CE, 3rd, Jain RK. Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery. Proc Natl Acad Sci USA. 2015;112:1827–1832. doi: 10.1073/pnas.1424563112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Deakin AS. Model for the growth of a solid in vitro tumor. Growth. 1975;39:159–165. [PubMed] [Google Scholar]
- 13.Dorhoi A, Reece ST, Kaufmann SH. For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection. Immunol Rev. 2011;240:235–251. doi: 10.1111/j.1600-065X.2010.00994.x. [DOI] [PubMed] [Google Scholar]
- 14.Durand RE, Raleigh JA. Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Res. 1998;58:3547–3550. [PubMed] [Google Scholar]
- 15.Dye C, Bassili A, Bierrenbach AL, Broekmans JF, Chadha VK, Glaziou P, Gopi PG, Hosseini M, Kim SJ, Manissero D, Onozaki I, Rieder HL, Scheele S, van Leth F, van der Werf M, Williams BG. Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet Infect Dis. 2008;8:233–243. doi: 10.1016/S1473-3099(07)70291-8. [DOI] [PubMed] [Google Scholar]
- 16.Ellner JJ. Review: the immune response in human tuberculosis–implications for tuberculosis control. J Infect Dis. 1997;176:1351–1359. doi: 10.1086/514132. [DOI] [PubMed] [Google Scholar]
- 17.Fogler HS. Elements of Chemical Reaction Engineering. Upper Saddle River, NJ: Prentice Hall; 2006. [Google Scholar]
- 18.Golub AS, Pittman RN. Oxygen dependence of respiration in rat spinotrapezius muscle in situ. Am J Physiol Heart Circ Physiol. 2012;303:H47–H56. doi: 10.1152/ajpheart.00131.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Grimes DR, Fletcher AG, Partridge M. Oxygen consumption dynamics in steady-state tumour models. R Soc Open Sci. 2014;1:140080. doi: 10.1098/rsos.140080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res. 1987;47:3039–3051. [PubMed] [Google Scholar]
- 21.Jain RK. Determinants of tumor blood flow: a review. Cancer Res. 1988;48:2641–2658. [PubMed] [Google Scholar]
- 22.Jain RK. The next frontier of molecular medicine: delivery of therapeutics. Nat Med. 1998;4:655–657. doi: 10.1038/nm0698-655. [DOI] [PubMed] [Google Scholar]
- 23.Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005;307:58–62. doi: 10.1126/science.1104819. [DOI] [PubMed] [Google Scholar]
- 24.Jain RK. Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. Cancer Cell. 2014;26:605–633. doi: 10.1016/j.ccell.2014.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Keren I, Minami S, Rubin E, Lewis K. Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio. 2011;2:e00100–e00111. doi: 10.1128/mBio.00100-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kiran KL, Jayachandran D, Lakshminarayanan S. Mathematical modelling of avascular tumour growth based on diffusion of nutrients and its validation. Can J Chem Eng. 2009;87:732–740. [Google Scholar]
- 27.Klinkenberg LG, Sutherland LA, Bishai WR, Karakousis PC. Metronidazole lacks activity against Mycobacterium tuberculosis in an in vivo hypoxic granuloma model of latency. J Infect Dis. 2008;198:275–283. doi: 10.1086/589515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Kumar A, Toledo JC, Patel RP, Lancaster JR, Jr, Steyn AJ. Mycobacterium tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor. Proc Natl Acad Sci USA. 2007;104:11568–11573. doi: 10.1073/pnas.0705054104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.McGoron AJ, Nair P, Schubert RW. Michaelis-Menten kinetics model of oxygen consumption by rat brain slices following hypoxia. Ann Biomed Eng. 1997;25:565–572. doi: 10.1007/BF02684195. [DOI] [PubMed] [Google Scholar]
- 30.Parandhaman DK, Narayanan S. Cell death paradigms in the pathogenesis of Mycobacterium tuberculosis infection. Front Cell Infect Microbiol. 2014;4:31. doi: 10.3389/fcimb.2014.00031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Qutub AA, Mac Gabhann F, Karagiannis ED, Vempati P, Popel AS. Multiscale models of angiogenesis. IEEE Eng Med Biol Mag. 2009;28:14–31. doi: 10.1109/MEMB.2009.931791. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Raleigh JA, Calkins-Adams DP, Rinker LH, Ballenger CA, Weissler MC, Fowler WC, Jr, Novotny DB, Varia MA. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res. 1998;58:3765–3768. [PubMed] [Google Scholar]
- 33.Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol. 2012;12:352–366. doi: 10.1038/nri3211. [DOI] [PubMed] [Google Scholar]
- 34.Rhoades ER, Geisel RE, Butcher BA, McDonough S, Russell DG. Cell wall lipids from Mycobacterium bovis BCG are inflammatory when inoculated within a gel matrix: characterization of a new model of the granulomatous response to mycobacterial components. Tuberculosis (Edinb) 2005;85:159–176. doi: 10.1016/j.tube.2004.10.001. [DOI] [PubMed] [Google Scholar]
- 35.Roose T, Chapman SJ, Maini PK. Mathematical models of avascular tumor growth. Siam Rev. 2007;49:179–208. [Google Scholar]
- 36.Russell DG. Who puts the tubercle in tuberculosis? Nat Rev Microbiol. 2007;5:39–47. doi: 10.1038/nrmicro1538. [DOI] [PubMed] [Google Scholar]
- 37.Russell DG, Barry CE, 3rd, Flynn JL. Tuberculosis: what we don’t know can, and does, hurt us. Science. 2010;328:852–856. doi: 10.1126/science.1184784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Rustad TR, Harrell MI, Liao R, Sherman DR. The enduring hypoxic response of Mycobacterium tuberculosis. PLoS One. 2008;3:e1502. doi: 10.1371/journal.pone.0001502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Rustad TR, Sherrid AM, Minch KJ, Sherman DR. Hypoxia: a window into Mycobacterium tuberculosis latency. Cell Microbiol. 2009;11:1151–1159. doi: 10.1111/j.1462-5822.2009.01325.x. [DOI] [PubMed] [Google Scholar]
- 40.Saini DK, Malhotra V, Dey D, Pant N, Das TK, Tyagi JS. DevR-DevS is a bona fide two-component system of Mycobacterium tuberculosis that is hypoxia-responsive in the absence of the DNA-binding domain of DevR. Microbiology. 2004;150:865–875. doi: 10.1099/mic.0.26218-0. [DOI] [PubMed] [Google Scholar]
- 41.Sakaguchi I, Ikeda N, Nakayama M, Kato Y, Yano I, Kaneda K. Trehalose 6,6′-dimycolate (Cord factor) enhances neovascularization through vascular endothelial growth factor production by neutrophils and macrophages. Infect Immun. 2000;68:2043–2052. doi: 10.1128/iai.68.4.2043-2052.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Sakamoto K. The pathology of Mycobacterium tuberculosis infection. Vet Pathol. 2012;49:423–439. doi: 10.1177/0300985811429313. [DOI] [PubMed] [Google Scholar]
- 43.Schultz DS, King WE. On the analysis of oxygen diffusion and reaction in biological systems. Math Biosci. 1987;83:179–190. [Google Scholar]
- 44.Secomb TW, Hsu R, Dewhirst MW, Klitzman B, Gross JF. Analysis of oxygen transport to tumor tissue by microvascular networks. Int J Radiat Oncol Biol Phys. 1993;25:481–489. doi: 10.1016/0360-3016(93)90070-c. [DOI] [PubMed] [Google Scholar]
- 45.Stylianopoulos T, Jain RK. Combining two strategies to improve perfusion and drug delivery in solid tumors. Proc Natl Acad Sci USA. 2013;110:18632–18637. doi: 10.1073/pnas.1318415110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Torres Filho IP, Leunig M, Yuan F, Intaglietta M, Jain RK. Noninvasive measurement of microvascular and interstitial oxygen profiles in a human tumor in SCID mice. Proc Natl Acad Sci USA. 1994;91:2081–2085. doi: 10.1073/pnas.91.6.2081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Truskey GA, Yuan F, Katz DF. Transport Phenomena in Biological Systems. Upper Saddle River, NJ: Prentice Hall; 2004. [Google Scholar]
- 48.Via LE, Lin PL, Ray SM, Carrillo J, Allen SS, Eum SY, Taylor K, Klein E, Manjunatha U, Gonzales J, Lee EG, Park SK, Raleigh JA, Cho SN, McMurray DN, Flynn JL, Barry CE., 3rd Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun. 2008;76:2333–2340. doi: 10.1128/IAI.01515-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Wayne LG. In vitro model of hypoxically induced non-replicating persistence of Mycobacterium tuberculosis. Methods Mol Med. 2001;54:247–269. doi: 10.1385/1-59259-147-7:247. [DOI] [PubMed] [Google Scholar]
- 50.Wayne LG, Hayes LG. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun. 1996;64:2062–2069. doi: 10.1128/iai.64.6.2062-2069.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Wayne LG, Sohaskey CD. Nonreplicating persistence of Mycobacterium tuberculosis. Annu Rev Microbiol. 2001;55:139–163. doi: 10.1146/annurev.micro.55.1.139. [DOI] [PubMed] [Google Scholar]
- 52.Wilson DF, Rumsey WL. Factors modulating the oxygen dependence of mitochondrial oxidative phosphorylation. Adv Exp Med Biol. 1988;222:121–131. doi: 10.1007/978-1-4615-9510-6_14. [DOI] [PubMed] [Google Scholar]
- 53.Wilson DF, Rumsey WL, Green TJ, Vanderkooi JM. The oxygen dependence of mitochondrial oxidative phosphorylation measured by a new optical method for measuring oxygen concentration. J Biol Chem. 1988;263:2712–2718. [PubMed] [Google Scholar]
- 54.Zhang Y, Shi W, Zhang W, Mitchison D. Mechanisms of pyrazinamide action and resistance. Microbiol Spectr. 2013;2:1–12. doi: 10.1128/microbiolspec.MGM2-0023-2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Zhou S, Cui Z, Urban JP. Factors influencing the oxygen concentration gradient from the synovial surface of articular cartilage to the cartilage-bone interface: a modeling study. Arthritis Rheum. 2004;50:3915–3924. doi: 10.1002/art.20675. [DOI] [PubMed] [Google Scholar]
- 56.Zumla AI, Gillespie SH, Hoelscher M, Philips PP, Cole ST, Abubakar I, McHugh TD, Schito M, Maeurer M, Nunn AJ. New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. Lancet Infect Dis. 2014;14:327–340. doi: 10.1016/S1473-3099(13)70328-1. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.